Home1801 • HKG
add
Innovent Biologics Inc
Previous close
$38.25
Day range
$37.50 - $42.00
Year range
$27.30 - $49.80
Market cap
67.82B HKD
Avg Volume
8.28M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.75B | 51.27% |
Operating expense | 1.72B | 3.70% |
Net income | -444.38M | 27.67% |
Net profit margin | -25.36 | 52.19% |
Earnings per share | — | — |
EBITDA | -418.96M | 45.38% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.97B | 19.68% |
Total assets | 20.63B | 17.28% |
Total liabilities | 8.10B | 18.09% |
Total equity | 12.53B | — |
Shares outstanding | 1.58B | — |
Price to book | 4.84 | — |
Return on assets | -5.82% | — |
Return on capital | -7.43% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -444.38M | 27.67% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
Apr 28, 2011
Website
Employees
4,872